期刊文献+

半乳糖凝集素3在心力衰竭中的研究进展 被引量:4

下载PDF
导出
摘要 半乳糖凝集素3(Gal-3)是一种可溶性的β-半乳糖苷结合蛋白,相对分子质量为(29~35)×10^3,可与细胞外基质、细胞内糖蛋白和细胞表面分子相互作用,存在于多种细胞的细胞质、细胞核、细胞表面以及细胞外基质,参与细胞黏附、增殖、活化、凋亡等,介导许多炎症性疾病的免疫应答状态。Gal-3能介导心肌中的巨噬细胞、肥大细胞浸润,增加心肌间质、血管周围纤维化及心脏胶原沉积,引起心肌肥厚、心肌顺应性减弱,而导致心力衰竭(HF)的发生。
作者 陈琼 张秀明
出处 《国际检验医学杂志》 CAS 2015年第2期249-251,共3页 International Journal of Laboratory Medicine
  • 相关文献

参考文献19

  • 1Yu LL~Ruifrok WP,Meissner M,et al. Genetic and pharmacolog- ical inhibition of galectin-3 prevents cardiae remodeling by inter- fering with myocardial fibrogenesis[J]. Circ Heart Fail, 2013,6 (1) :107.
  • 2Durnic J, Dabelie S, Flogel M. Galectin-3: an open-ended story [J]. Biochim Biophys Acta, 2006,1760 (4) : 616-635.
  • 3Christenson RH,Duh SH,Wu AH,et al. Multi-center determina- tion of galectin-3 assay performance characteristics:Anatomy of a novel assay for use in heart failure[J]. Clin Biochem, 2010,43 (7/ 8) : 683-690.
  • 4韩雪晶,贾克刚.半乳糖凝集素3作为心力衰竭新的生物标记物的研究进展[J].中华老年心脑血管病杂志,2013,15(8):882-884. 被引量:11
  • 5La'ulu SL, Apple FS, Murakami MM, et al. Performance charac-teristics of the ARCHITECT Galectin-3 assay[J]. Clin Biochem, 2013,46(1/2) :119-122.
  • 6Sharma U,Rhaleb NE,Pokharel S, et al. Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage [ J ]. Am J Physiol Heart C, 2008,294 (3) : 1226-1232.
  • 7Dhirapong A, Lieo A, Leung P, et al. The immunological potential of Galectin-1 and -3 [J]. Autoimmun Rev, 2009,8 (1) : 360-363.
  • 8Szadkowska I,Wlaze? RN,Miga? a M,et al. The association be- tween galectin-3 and clinical parameters in patients with first a- cute myocardial infarction treated with primary percutaneous cor- onary angioplasty[J]. Cardiol J, 2013,20(6) :577-582.
  • 9Shah RV, Januzzi J. Soluble ST2 and galectin-3 in heart failure [J]. ClinLabMed,2014,34(1):87.
  • 10van Kimmenadc RR, Januzzi JL Jr, Ellinor PT, et al. Utility of aminotenminal pro-brain natriuretie peptide, galectin-3, and aplin for the evaluation of patients with acute heart failure[J]. J Am Coil Cardiol. 2006,48(6): 1217-1224.

二级参考文献24

  • 1Yang RY, Rabinovich GA, Liu FT. Galectins : structure, func tion and therapeutic potential. Expert Rev Mol Med, 2008, 10:e17.
  • 2Dumic J, Dabelic S, Flogel M. Galectins: an open ended story. Biochim Biophys Acta, 2006,1760 :616- 635.
  • 3Eude-Le P,Gendronneau G,Dang T,et al. Genetic assessment of the importance of galectin 3 in cancer initiation, progres sion, and dissemination in mice. Glycobiology, 2009, 19 : 68 -75.
  • 4Jiang JX, Chen X, Hsu DK, et al. Galectin 3 modulates phago cytosis induced stellate cell activation and liver fibrosis in vi Liver Physiol, 2012,302 : G439-G446.
  • 5Okamura l)M,Pasichnyk K,Lopez Guisa JM,et al. Galeetin 3 preserves renal tubules and modulates extracellular matrix re modeling in progressive fibrosis. Am J Physiol Renal Pbysiol, 2011,300:F245- F253.
  • 6Felker GM,Fiuzat M,Shaw LK,et al. Galectin 3 in ambulato ry patients with heart failure: results from the HF-ACTION study.Cire Heart Fail,2012,5:72- 78.
  • 7de Boer RA, Lok DJ, Jaarsma T, et al. Predictive value of plasma galectin 3 levels in heart failure with reduced and pre served ejection fraction. Ann Med, 2011,43 : 60 -68.
  • 8Tang WH, Shreatha K, Shao Z, et al. Usefulness of plasma galectin 3 levels in systolic heart failure to predict renal insuf ficiency and survival. Am J Cardiol, 2011,108 : 385- 390.
  • 9de Boer RA, Voors AA, Muntendam P, et al. Galectin-3 : a no vel mediator of heart failure development and progression. Eur J Heart Fail,2009,11:811- 817.
  • 10Anand IS,Rector TS,Kuskowski M, et al. Baseline and serial measurements of galectin 3 in patients with heart failure: rela tionship to prognosis and effect of treatment with valsanan in the Val HEFT. EurJ Heart Fail,2013,15:511- 518.

共引文献11

同被引文献39

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部